A New Jersey federal judge on Friday approved a diverse group of attorneys, a majority of whom are women, to serve as the plaintiff steering committee for consumers alleging that Johnson & Johnson's pharmaceutical unit concealed a side effect of bladder cyst medicine that results in serious eye damage. Associate Rachel L. Shkolnik was named to the Plaintiffs' Executive Committee. Download